285 related articles for article (PubMed ID: 18033025)
21. Hemodialysis for hyperammonemia associated with ornithine transcarbamylase deficiency.
Collen JF; Das NP; Koff JM; Neff RT; Abbott KC
Appl Clin Genet; 2008; 1():1-5. PubMed ID: 23776342
[TBL] [Abstract][Full Text] [Related]
22. In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle.
Lee B; Yu H; Jahoor F; O'Brien W; Beaudet AL; Reeds P
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8021-6. PubMed ID: 10869432
[TBL] [Abstract][Full Text] [Related]
23. The utility of EEG monitoring in neonates with hyperammonemia due to inborn errors of metabolism.
Wiwattanadittakul N; Prust M; Gaillard WD; Massaro A; Vezina G; Tsuchida TN; Gropman AL
Mol Genet Metab; 2018 Nov; 125(3):235-240. PubMed ID: 30197275
[TBL] [Abstract][Full Text] [Related]
24. Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment.
Molema F; Gleich F; Burgard P; van der Ploeg AT; Summar ML; Chapman KA; Lund AM; Rizopoulos D; Kölker S; Williams M;
Mol Genet Metab; 2019 Apr; 126(4):397-405. PubMed ID: 30827756
[TBL] [Abstract][Full Text] [Related]
25. Adult-onset diagnosis of urea cycle disorders: Results of a French cohort of 71 patients.
Toquet S; Spodenkiewicz M; Douillard C; Maillot F; Arnoux JB; Damaj L; Odent S; Moreau C; Redonnet-Vernhet I; Mesli S; Servais A; Noel E; Charriere S; Rigalleau V; Lavigne C; Kaphan E; Roubertie A; Besson G; Bigot A; Servettaz A; Mochel F; Garnotel R
J Inherit Metab Dis; 2021 Sep; 44(5):1199-1214. PubMed ID: 34014557
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: On the basis of information from a European multicenter registry.
Molema F; Gleich F; Burgard P; van der Ploeg AT; Summar ML; Chapman KA; Barić I; Lund AM; Kölker S; Williams M;
J Inherit Metab Dis; 2019 Nov; 42(6):1162-1175. PubMed ID: 30734935
[TBL] [Abstract][Full Text] [Related]
27. [Enzyme defects of the urea cycle in differential acute encephalopathy diagnosis in adulthood. Diagnosis and current therapy concepts].
Schwarz S; Schwab S; Hoffmann GF
Nervenarzt; 1999 Feb; 70(2):111-8. PubMed ID: 10098145
[TBL] [Abstract][Full Text] [Related]
28. Late-onset ornithine transcarbamylase deficiency: a rare cause of recurrent abnormal behavior in adults.
Hidaka M; Higashi E; Uwatoko T; Uwatoko K; Urashima M; Takashima H; Watanabe Y; Kitazono T; Sugimori H
Acute Med Surg; 2020; 7(1):e565. PubMed ID: 32995020
[TBL] [Abstract][Full Text] [Related]
29. Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with urea cycle disorders.
McGuire PJ; Lee HS; ; Summar ML
J Pediatr; 2013 Dec; 163(6):1705-1710.e1. PubMed ID: 24084106
[TBL] [Abstract][Full Text] [Related]
30. [A newborn infant with hyperventilation].
Lindemann R; Myhre MC; Bakken M; Fugelseth D; Rustad CF; Woldseth B
Tidsskr Nor Laegeforen; 2008 Jun; 128(13):1535-6. PubMed ID: 18604903
[TBL] [Abstract][Full Text] [Related]
31. Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.
Heringlake S; Böker K; Manns M
Digestion; 1997; 58(1):83-6. PubMed ID: 9018015
[TBL] [Abstract][Full Text] [Related]
32. Fatal initial adult-onset presentation of urea cycle defect.
Lien J; Nyhan WL; Barshop BA
Arch Neurol; 2007 Dec; 64(12):1777-9. PubMed ID: 18071043
[TBL] [Abstract][Full Text] [Related]
33. Urea cycle disorders: clinical presentation outside the newborn period.
Smith W; Kishnani PS; Lee B; Singh RH; Rhead WJ; Sniderman King L; Smith M; Summar M
Crit Care Clin; 2005 Oct; 21(4 Suppl):S9-17. PubMed ID: 16227115
[TBL] [Abstract][Full Text] [Related]
34. Inborn errors of urea synthesis.
Batshaw ML
Ann Neurol; 1994 Feb; 35(2):133-41. PubMed ID: 7906500
[TBL] [Abstract][Full Text] [Related]
35. Hyperammonemia in urea cycle disorders: role of the nephrologist.
Mathias RS; Kostiner D; Packman S
Am J Kidney Dis; 2001 May; 37(5):1069-80. PubMed ID: 11325692
[TBL] [Abstract][Full Text] [Related]
36. Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations.
Legras A; Labarthe F; Maillot F; Garrigue MA; Kouatchet A; Ogier de Baulny H
Crit Care Med; 2002 Jan; 30(1):241-4. PubMed ID: 11902270
[TBL] [Abstract][Full Text] [Related]
37. Effect of lysine infusion on urea cycle in lysinuric protein intolerance.
Lukkarinen M; Näntö-Salonen K; Pulkki K; Mattila K; Simell O
Metabolism; 2000 May; 49(5):621-5. PubMed ID: 10831173
[TBL] [Abstract][Full Text] [Related]
38. Neurological implications of urea cycle disorders.
Gropman AL; Summar M; Leonard JV
J Inherit Metab Dis; 2007 Nov; 30(6):865-79. PubMed ID: 18038189
[TBL] [Abstract][Full Text] [Related]
39. Late-onset ornithine transcarbamylase deficiency associated with hyperammonemia.
Daijo K; Kawaoka T; Nakahara T; Nagaoki Y; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Hara K; Tajima G; Kobayashi M; Chayama K
Clin J Gastroenterol; 2017 Aug; 10(4):383-387. PubMed ID: 28597413
[TBL] [Abstract][Full Text] [Related]
40. Cross-sectional multicenter study of patients with urea cycle disorders in the United States.
Tuchman M; Lee B; Lichter-Konecki U; Summar ML; Yudkoff M; Cederbaum SD; Kerr DS; Diaz GA; Seashore MR; Lee HS; McCarter RJ; Krischer JP; Batshaw ML;
Mol Genet Metab; 2008 Aug; 94(4):397-402. PubMed ID: 18562231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
